LABCORP
LIVE

Serial Number

87158027

Owner

LABORATORY CORPORATION OF AMERICA HOLDINGS

Attorney

William M. Bryner

First Use Date

Jun 30, 2021

Filing Date

Sep 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LABCORP Trademark

Serial Number: 87158027 • Registration: 6563087

LABCORP is a trademark filed by LABORATORY CORPORATION OF AMERICA HOLDINGS on September 1, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

LABORATORY CORPORATION OF AMERICA HOLDINGS (342 trademarks)

531 SOUTH SPRING STREET
BURLINGTON, NC 27215

Entity Type: 03

Trademark Details

Filing Date

September 1, 2016

Registration Date

November 16, 2021

First Use Anywhere

June 30, 2021

First Use in Commerce

June 30, 2021

Published for Opposition

July 17, 2018

Goods & Services

Downloadable electronic publications, books, brochures, pamphlets, articles, technical manuals in the field of medical testing

Printed publications, namely, books, brochures, pamphlets, articles, technical manuals, instructional and teaching materials, and reports in the field of medical testing

Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; tracking, monitoring, analyzing, generating, and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices

Regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; forecasting drug supplies for clinical trials; recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market intelligence, market research, marketing services, data collection, data submission, database management, and project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology

Regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices; regulatory compliance consulting in the field of food safety and nutritional labeling; information and advisory services relating to the foregoing

Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; medical testing for diagnostic, treatment, or screening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care and healthcare; medical consulting in the field of patient management and outcomes, providing an online computer database in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring information in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing a website featuring medical information in the field of patient management and outcomes

Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemical; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; testing of laboratory animals for scientific research purposes; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemical; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safety, food packaging, and nutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; Acting as an application service provider featuring software for use in database and record management in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposes, testing for forensic research purposes, testing for quality control purposes, genetic testing for scientific research purposes, and medical and scientific research in the field of, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing temporary use of online non-downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; consulting services in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing an online computer database in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing a website featuring information in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; medical testing for quality control

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 16, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 9, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 8, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 13, 2021 SUPC
USE AMENDMENT FILED
Sep 8, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 8, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2021 EXRA
SOU EXTENSION 5 GRANTED
Mar 26, 2021 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 26, 2021 AITU
SOU EXTENSION 5 FILED
Mar 11, 2021 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 11, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2020 EXRA
SOU EXTENSION 4 GRANTED
Sep 10, 2020 EX4G
SOU EXTENSION 4 FILED
Sep 10, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 10, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2020 EXRA
SOU EXTENSION 3 GRANTED
Mar 10, 2020 EX3G
SOU EXTENSION 3 FILED
Mar 10, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 10, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2019 EXRA
SOU EXTENSION 2 GRANTED
Sep 11, 2019 EX2G
SOU EXTENSION 2 FILED
Sep 11, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2019 EEXT
ASSIGNED TO EXAMINER
Jul 5, 2019 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2019 EXRA
SOU EXTENSION 1 GRANTED
Mar 8, 2019 EX1G
SOU EXTENSION 1 FILED
Mar 8, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 8, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 8, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 8, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 8, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 8, 2018 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2018 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2018 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2018 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 9, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 30, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 7, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Sep 8, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2016 NWOS
NEW APPLICATION ENTERED
Sep 5, 2016 NWAP